 |
test site |
|
|||||
| Executive Editor.....Anne-Merete Robbs CEO..............Stan Swartz | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| "Dr. Vollmer is close to a MS cure..but..he needs you to help by joining a trial!" | ||||||||||||||||||||||
Stan Swartz, CEO, The MD Health Channel "Plus...You'll receive all medication and study based procedures at NO CHARGE" . |
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
| "MY EDUCATIONAL VIDEO ON MS" | ||||||||||||||||||||||
 For Broadband Users Runtime: 4:17 WMV |
||||||||||||||||||||||
| "THE VOLUNTARY SUSPENSION OF TYSABRI BY BIOGEN IDEC AND ELAN" | ||||||||||||||||||||||
 For Broadband Users Runtime: 4:17 WMV |
||||||||||||||||||||||
 |
||||||||||||||||||||||
 |
||||||||||||||||||||||
| Timothy L. Vollmer M.D. Director, Barrow NeuroImmunology Program Barrow Neurological Institute St. Joseph's Hospital and Medical Center |
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
| Previious Posts | ||||||||||||||||||||||
|
||||||||||||||||||||||
| MS NEWS ARCHIVES: by week | ||||||||||||||||||||||
| December 2005 | ||||||||||||||||||||||
| January 2006 | ||||||||||||||||||||||
| May 2006 | ||||||||||||||||||||||
| June 2006 | ||||||||||||||||||||||
| October 2006 | ||||||||||||||||||||||
| October 2013 | ||||||||||||||||||||||
| November 2013 | ||||||||||||||||||||||
| December 2013 | ||||||||||||||||||||||
| April 2014 | ||||||||||||||||||||||
Thursday
FORMER BRISTOL-MYERS SQUIBB EXECUTIVE SENT TO PRISON FOR INSIDER TRADING
When Bristol-Myers Squibb ($BMY) wanted to take over a company, execs turns to Robert Ramnarine in their Princeton, NJ, office to do the confidential due diligence work on the target company's pension plan. But his plan for feathering his own nest with the insider information he picked up is leading to early retirement--in prison. Ramnarine was sentenced to one year and one day of jail time after pleading guilty to one count of securities fraud related to the ex-exec's purchase of options on Amylin stock as Bristol-Myers readied its $5.3 billion buyout last year. As Reuters reported, Ramnarine did a little online sleuthing on how insider trading is detected--evidently without realizing the Internet searches on insider trading can help make a case against you.
READ MORE
When Bristol-Myers Squibb ($BMY) wanted to take over a company, execs turns to Robert Ramnarine in their Princeton, NJ, office to do the confidential due diligence work on the target company's pension plan. But his plan for feathering his own nest with the insider information he picked up is leading to early retirement--in prison. Ramnarine was sentenced to one year and one day of jail time after pleading guilty to one count of securities fraud related to the ex-exec's purchase of options on Amylin stock as Bristol-Myers readied its $5.3 billion buyout last year. As Reuters reported, Ramnarine did a little online sleuthing on how insider trading is detected--evidently without realizing the Internet searches on insider trading can help make a case against you.
READ MORE